Tag: licensing

Price adjustment, combined with federal tax credit, provides $15,000 in savings

CORAL GABLES, Fla., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced the National Comprehensive Cancer Network^® (NCCN) Clinical Practice Guidelines in Oncology (NCCN Guidelines^®) for Small Cell Lung Cancer (SCLC) now include new additions involving Lambert Eaton myasthenic syndrome (LEMS), amifampridine (FIRDAPSE^®), and the tests for PQ- and N-type voltage-gated calcium channel (VGCC) antibodies.

SPOKANE, Wash., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Avista Corp. (NYSE: AVA) today announced financial results for the second quarter of 2025. Net income and earnings per diluted share for the second quarter and year-to-date 2025 compared to the same periods in 2024 are presented in the table below (dollars in millions, except per-share data):

BEIJING, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Symposium on International Cooperation for Digital Product Passport (DPP) and International Standards for Entire Lifecycle Management," organized by Zhongguancun Industry & Information Research Institute of Two-Dimensional Code Technology (ZIIOT), International Identification Code Industry Alliance (ICA), and the IEC 63538 Working Group, concluded successfully in Beijing. It unveiled the groundbreaking MA-DPP Universal Framework V1.0, an open international public good, providing standardized solutions for global supply chain digital transformation while seeking worldwide partners for joint implementation to facilitate smooth and stable global supply chains.